U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Drugs@FDA

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 079028
Company: WATSON LABS
Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
GALANTAMINE HYDROBROMIDE GALANTAMINE HYDROBROMIDE EQ 8MG BASE CAPSULE, EXTENDED RELEASE;ORAL Prescription AB No No
GALANTAMINE HYDROBROMIDE GALANTAMINE HYDROBROMIDE EQ 16MG BASE CAPSULE, EXTENDED RELEASE;ORAL Prescription AB No No
GALANTAMINE HYDROBROMIDE GALANTAMINE HYDROBROMIDE EQ 24MG BASE CAPSULE, EXTENDED RELEASE;ORAL Prescription AB No No
Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
12/15/2008 ORIG-1 Approval

Label is not available on this site.

Supplements
Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels, Patient Package Insert Note Url
06/14/2022 SUPPL-14 Labeling-Package Insert

Label is not available on this site.

06/14/2022 SUPPL-13 Labeling-Container/Carton Labels, Labeling-Package Insert

Label is not available on this site.

06/14/2022 SUPPL-11 Labeling-Package Insert

Label is not available on this site.

12/14/2017 SUPPL-10 Labeling-Package Insert

Label is not available on this site.

GALANTAMINE HYDROBROMIDE

CAPSULE, EXTENDED RELEASE;ORAL; EQ 8MG BASE
TE Code = AB

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
GALANTAMINE HYDROBROMIDE GALANTAMINE HYDROBROMIDE EQ 8MG BASE CAPSULE, EXTENDED RELEASE;ORAL Prescription No AB 204895 AUROBINDO PHARMA
GALANTAMINE HYDROBROMIDE GALANTAMINE HYDROBROMIDE EQ 8MG BASE CAPSULE, EXTENDED RELEASE;ORAL Prescription No AB 078189 BARR
GALANTAMINE HYDROBROMIDE GALANTAMINE HYDROBROMIDE EQ 8MG BASE CAPSULE, EXTENDED RELEASE;ORAL Prescription No AB 090178 SUN PHARM
GALANTAMINE HYDROBROMIDE GALANTAMINE HYDROBROMIDE EQ 8MG BASE CAPSULE, EXTENDED RELEASE;ORAL Prescription No AB 079028 WATSON LABS

CAPSULE, EXTENDED RELEASE;ORAL; EQ 16MG BASE
TE Code = AB

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
GALANTAMINE HYDROBROMIDE GALANTAMINE HYDROBROMIDE EQ 16MG BASE CAPSULE, EXTENDED RELEASE;ORAL Prescription No AB 204895 AUROBINDO PHARMA
GALANTAMINE HYDROBROMIDE GALANTAMINE HYDROBROMIDE EQ 16MG BASE CAPSULE, EXTENDED RELEASE;ORAL Prescription No AB 078189 BARR
GALANTAMINE HYDROBROMIDE GALANTAMINE HYDROBROMIDE EQ 16MG BASE CAPSULE, EXTENDED RELEASE;ORAL Prescription No AB 090178 SUN PHARM
GALANTAMINE HYDROBROMIDE GALANTAMINE HYDROBROMIDE EQ 16MG BASE CAPSULE, EXTENDED RELEASE;ORAL Prescription No AB 079028 WATSON LABS

CAPSULE, EXTENDED RELEASE;ORAL; EQ 24MG BASE
TE Code = AB

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
GALANTAMINE HYDROBROMIDE GALANTAMINE HYDROBROMIDE EQ 24MG BASE CAPSULE, EXTENDED RELEASE;ORAL Prescription No AB 204895 AUROBINDO PHARMA
GALANTAMINE HYDROBROMIDE GALANTAMINE HYDROBROMIDE EQ 24MG BASE CAPSULE, EXTENDED RELEASE;ORAL Prescription No AB 078189 BARR
GALANTAMINE HYDROBROMIDE GALANTAMINE HYDROBROMIDE EQ 24MG BASE CAPSULE, EXTENDED RELEASE;ORAL Prescription No AB 090178 SUN PHARM
GALANTAMINE HYDROBROMIDE GALANTAMINE HYDROBROMIDE EQ 24MG BASE CAPSULE, EXTENDED RELEASE;ORAL Prescription No AB 079028 WATSON LABS
Back to Top